BIOMARIN PHARMACEUTICAL INC Quarterly Return On Assets in % from Q1 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Return On Assets history and growth rate from Q1 2011 to Q3 2024.
  • Biomarin Pharmaceutical Inc Return On Assets for the quarter ending September 30, 2024 was 4.67 %, a 107% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Return On Assets for 2023 was 2.52 %, a 10.5% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Return On Assets for 2022 was 2.28 %.
  • Biomarin Pharmaceutical Inc annual Return On Assets for 2021 was -1.08 %, a 107% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 4.67 +2.41 +107% Jul 1, 2024 Sep 30, 2024
Q2 2024 3.73 +2.17 +139% Apr 1, 2024 Jun 30, 2024
Q1 2024 3.04 +1.9 +167% Jan 1, 2024 Mar 31, 2024
Q4 2023 2.52 +0.24 +10.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 2.25 +0.88 +64.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 1.56 +0.67 +74.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 1.14 +0.48 +73% Jan 1, 2023 Mar 31, 2023
Q4 2022 2.28 +3.36 Oct 1, 2022 Dec 31, 2022
Q3 2022 1.37 +1.19 +645% Jul 1, 2022 Sep 30, 2022
Q2 2022 0.89 -13.1 -93.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 0.66 -13 -95.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -1.08 -16.6 -107% Oct 1, 2021 Dec 31, 2021
Q3 2021 0.18 -16.1 -98.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 14 +11.5 +453% Apr 1, 2021 Jun 30, 2021
Q1 2021 13.7 +11.2 +451% Jan 1, 2021 Mar 31, 2021
Q4 2020 15.5 +16 Oct 1, 2020 Dec 31, 2020
Q3 2020 16.3 +17.3 Jul 1, 2020 Sep 30, 2020
Q2 2020 2.54 +4.99 Apr 1, 2020 Jun 30, 2020
Q1 2020 2.48 +4.45 Jan 1, 2020 Mar 31, 2020
Q4 2019 -0.53 +1.16 +68.9% Oct 1, 2019 Dec 31, 2019
Q3 2019 -0.95 +1.74 +64.6% Jul 1, 2019 Sep 30, 2019
Q2 2019 -2.46 +0.25 +9.23% Apr 1, 2019 Jun 30, 2019
Q1 2019 -1.97 +1.28 +39.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 -1.68 +1.04 +38.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -2.69 +1.08 +28.6% Jul 1, 2018 Sep 30, 2018
Q2 2018 -2.71 +1.87 +40.8% Apr 1, 2018 Jun 30, 2018
Q1 2018 -3.25 +11.9 +78.5% Jan 1, 2018 Mar 31, 2018
Q4 2017 -2.73 +14.5 +84.2% Oct 1, 2017 Dec 31, 2017
Q3 2017 -3.78 +9.37 +71.3% Jul 1, 2017 Sep 30, 2017
Q2 2017 -4.58 +10.3 +69.1% Apr 1, 2017 Jun 30, 2017
Q1 2017 -15.1 -10 -196% Jan 1, 2017 Mar 31, 2017
Q4 2016 -17.2 -12.6 -268% Oct 1, 2016 Dec 31, 2016
Q3 2016 -13.2 -3.89 -42% Jul 1, 2016 Sep 30, 2016
Q2 2016 -14.9 -7.93 -114% Apr 1, 2016 Jun 30, 2016
Q1 2016 -5.11 +0.88 +14.7% Jan 1, 2016 Mar 31, 2016
Q4 2015 -4.69 +0.89 +15.9% Oct 1, 2015 Dec 31, 2015
Q3 2015 -9.25 -3.87 -71.9% Jul 1, 2015 Sep 30, 2015
Q2 2015 -6.93 +1.8 +20.6% Apr 1, 2015 Jun 30, 2015
Q1 2015 -5.98 +2.97 +33.2% Jan 1, 2015 Mar 31, 2015
Q4 2014 -5.58 +4.4 +44.1% Oct 1, 2014 Dec 31, 2014
Q3 2014 -5.39 +5.09 +48.6% Jul 1, 2014 Sep 30, 2014
Q2 2014 -8.73 -1.17 -15.5% Apr 1, 2014 Jun 30, 2014
Q1 2014 -8.95 -0.64 -7.7% Jan 1, 2014 Mar 31, 2014
Q4 2013 -9.99 -2.32 -30.3% Oct 1, 2013 Dec 31, 2013
Q3 2013 -10.5 -4.3 -69.6% Jul 1, 2013 Sep 30, 2013
Q2 2013 -7.56 -0.17 -2.3% Apr 1, 2013 Jun 30, 2013
Q1 2013 -8.31 -2.64 -46.5% Jan 1, 2013 Mar 31, 2013
Q4 2012 -7.67 -3.48 -83.1% Oct 1, 2012 Dec 31, 2012
Q3 2012 -6.18 -3.1 -101% Jul 1, 2012 Sep 30, 2012
Q2 2012 -7.39 -22.9 -148% Apr 1, 2012 Jun 30, 2012
Q1 2012 -5.67 -22.5 -134% Jan 1, 2012 Mar 31, 2012
Q4 2011 -4.19 Oct 1, 2011 Dec 31, 2011
Q3 2011 -3.08 Jul 1, 2011 Sep 30, 2011
Q2 2011 15.5 Apr 1, 2011 Jun 30, 2011
Q1 2011 16.8 Jan 1, 2011 Mar 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.